Literature DB >> 8741080

Survival in multiple system atrophy: a study of prognostic factors in 59 cases.

D Testa1, G Filippini, M Farinotti, E Palazzini, T Caraceni.   

Abstract

The various clinical features of multiple system atrophy (MSA) make the diagnosis of the disease difficult, especially in its early stages, when signs of differentiated neuroanatomical system involvement have not yet appeared. Mortality studies may be affected by the variability of the diagnostic criteria and selection bias. We used strict clinical and MRI criteria to diagnose MSA in 59 patients. Patients with parkinsonian and cerebellar onset were compared. Median survival time from the onset of the first motor symptom was 7.5 years. Our results indicated a trend (P = 0.09) for the Northwestern University Disability Scale score to correlate with mortality, but we failed to find other characteristics identifying subgroups or predictors for survival.

Entities:  

Mesh:

Year:  1996        PMID: 8741080     DOI: 10.1007/bf00868999

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  A method for evaluating disability in patients with Parkinson's disease.

Authors:  G J CANTER; R DE LA TORRE; M MIER
Journal:  J Nerv Ment Dis       Date:  1961-08       Impact factor: 2.254

2.  Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology.

Authors:  T Klockgether; G Schroth; H C Diener; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

3.  Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.

Authors:  J G Graham; D R Oppenheimer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-02       Impact factor: 10.154

4.  Cognitive and motor performance in multiple system atrophy and Parkinson's disease compared.

Authors:  D Testa; V Fetoni; P Soliveri; M Musicco; E Palazzini; F Girotti
Journal:  Neuropsychologia       Date:  1993-02       Impact factor: 3.139

5.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

Authors:  G K Wenning; Y Ben Shlomo; M Magalhães; S E Daniel; N P Quinn
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

Review 6.  Cellular pathology of multiple system atrophy: a review.

Authors:  P L Lantos; M I Papp
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

Review 7.  Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence.

Authors:  J P Larsen; E Dupont; E Tandberg
Journal:  Acta Neurol Scand       Date:  1994-04       Impact factor: 3.209

8.  Clinicopathological study of 35 cases of multiple system atrophy.

Authors:  G K Wenning; Y Ben-Shlomo; M Magalhães; S E Daniel; N P Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

9.  Multiple system atrophy. Clinical and MR observations on 42 cases.

Authors:  D Testa; M Savoiardo; V Fetoni; L Strada; E Palazzini; G Bertulezzi; F Girotti
Journal:  Ital J Neurol Sci       Date:  1993-04

10.  A study of parkinsonism in multiple system atrophy: clinical and MRI correlation.

Authors:  M Wakai; A Kume; A Takahashi; T Ando; Y Hashizume
Journal:  Acta Neurol Scand       Date:  1994-10       Impact factor: 3.209

View more
  12 in total

Review 1.  How to diagnose MSA early: the role of magnetic resonance imaging.

Authors:  K Seppi; M F H Schocke; G K Wenning; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

2.  Progression of parkinsonism in multiple system atrophy.

Authors:  Klaus Seppi; Farid Yekhlef; Anja Diem; Elisabeth Luginger Wolf; Joerg Mueller; François Tison; Niall P Quinn; Werner Poewe; Gregor K Wenning
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

3.  Multiple system atrophy: prognostic indicators of survival.

Authors:  Juan J Figueroa; Wolfgang Singer; Ajay Parsaik; Eduardo E Benarroch; J Eric Ahlskog; Robert D Fealey; Joseph E Parisi; Paola Sandroni; Jay Mandrekar; Valeria Iodice; Phillip A Low; James H Bower
Journal:  Mov Disord       Date:  2014-06-07       Impact factor: 10.338

4.  Assessment of cardiovascular autonomic dysfunction in multiple system atrophy.

Authors:  S Kitae; Y Murata; N Tachiki; M Okazaki; T Harada; S Nakamura
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

5.  Dystonia in multiple system atrophy.

Authors:  S M Boesch; G K Wenning; G Ransmayr; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

6.  Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.

Authors:  P Soliveri; D Monza; D Paridi; F Carella; S Genitrini; D Testa; F Girotti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

7.  Epidemiology of Multiple System Atrophy in Hokkaido, the Northernmost Island of Japan.

Authors:  Ken Sakushima; Naoki Nishimoto; Masanori Nojima; Masaaki Matsushima; Ichiro Yabe; Norihiro Sato; Mitsuru Mori; Hidenao Sasaki
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

8.  Clinical features and autonomic testing predict survival in multiple system atrophy.

Authors:  Elizabeth A Coon; David M Sletten; Mariana D Suarez; Jay N Mandrekar; J Eric Ahlskog; James H Bower; Joseph Y Matsumoto; Michael H Silber; Eduardo E Benarroch; Robert D Fealey; Paola Sandroni; Phillip A Low; Wolfgang Singer
Journal:  Brain       Date:  2015-09-13       Impact factor: 13.501

9.  The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

Authors:  Paul McCrone; Christine Anne Mary Payan; Martin Knapp; Albert Ludolph; Yves Agid; P Nigel Leigh; Gilbert Bensimon
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Authors:  Gilbert Bensimon; Albert Ludolph; Yves Agid; Marie Vidailhet; Christine Payan; P Nigel Leigh
Journal:  Brain       Date:  2008-11-23       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.